« Return to News | Clinical Intelligence

Top Stories for the Week of Jan. 8th 2007

Tuesday, January 9, 2007 10:21 AM

Top News

Accelovance Offers CRO Services in the U.S.

Maryland-based clinical trial company Accelovance has expanded its services to include a contract research division in the United States. Prior to broadening its business offerings, the company conducted clinical trials through a network of owned sites. Although the company already operates a CRO unit in China through a wholly-owned foreign enterprise in Beijing, this would be its first foray into fully managing trials in the U.S.

Kendle Opens Office in Sweden

Cincinnati-based contract research organization (CRO) Kendle International has opened a new office and operations in Uppsala, Sweden. The unit will handle phase II through IV trials throughout Scandinavia.   

Other breaking news...      

  • Medpace choses Mortara Instrument...
  • Afferenz partners with ClinInvent...

Company Profile: An interview with Young Jack Lee, president Lifecord Stat-Korea.

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.